Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 24832917)

1.

Asymmetric anterior uveitis as a delayed complication of treatment with systemic high-dose cytosine-arabinoside: a case report and literature review.

Grewal DS, Holland PM, Frankfurt O, Pyatetsky D.

Ocul Immunol Inflamm. 2014 Aug;22(4):322-5. doi: 10.3109/09273948.2013.801990. Epub 2014 May 15. Review. No abstract available.

PMID:
24832917
2.

Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia.

Kantarjian HM, Martinelli G, Jabbour EJ, Quintás-Cardama A, Ando K, Bay JO, Wei A, Gröpper S, Papayannidis C, Owen K, Pike L, Schmitt N, Stockman PK, Giagounidis A; SPARK-AML1 Investigators.

Cancer. 2013 Jul 15;119(14):2611-9. doi: 10.1002/cncr.28113. Epub 2013 Apr 19.

3.

Does high-dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?

Wiernik A, Sperr WR, Weisdorf D, Valent P, Ustun C.

Am J Hematol. 2013 Jun;88(6):533-4. doi: 10.1002/ajh.23440. Epub 2013 May 2. No abstract available.

PMID:
23526441
4.

[A man with neutropenic fever].

Ham JC, Ruijs GJ, van Marwijk Kooy MR.

Ned Tijdschr Geneeskd. 2013;157(12):A5997. Dutch.

PMID:
23515043
5.

Sense and nonsense of high-dose cytarabine for acute myeloid leukemia.

Löwenberg B.

Blood. 2013 Jan 3;121(1):26-8. doi: 10.1182/blood-2012-07-444851. Review.

6.

Risk factors for early death after high-dose cytosine arabinoside (HiDAC)-based chemotherapy for adult AML.

van der Jagt A, Muirhead J, Seymour JF, Bradstock KF, Paul E, Wei A.

Leukemia. 2012 Feb;26(2):362-5. doi: 10.1038/leu.2011.201. Epub 2011 Aug 12. No abstract available.

PMID:
21836615
7.

Anterior uveitis associated with high-dose cytosine arabinoside.

Fintelmann RE, Qian Y, Skalet A, Jeng BH.

Ocul Immunol Inflamm. 2010 Dec;18(6):485-7. doi: 10.3109/09273948.2010.510258. Epub 2010 Oct 1.

PMID:
20887203
8.

[Acute anterior uveitis].

Khan AA, Kelly RJ, Carrim ZI.

Praxis (Bern 1994). 2010 Feb 17;99(4):249-50. doi: 10.1024/1661-8157/a000036. German. No abstract available.

PMID:
20166051
9.

Severe anterior uveitis as a complication of high-dose cytosine-arabinoside.

Moberg J, Carlsson M, Holm C, Koranyi G.

Acta Ophthalmol. 2009 Nov;87(8):922-3. doi: 10.1111/j.1755-3768.2009.01673.x. Epub . No abstract available.

PMID:
19799589
10.

Cytarabine-associated lymphoid dyscrasia with atypical T CD30+ infiltrate in a patient suffering from acute nonlymphoblastic leukaemia.

Peñate Y, Guillermo N, Hernández-Machín B, Montenegro T, Borrego L.

Br J Dermatol. 2009 May;160(5):1122-3. doi: 10.1111/j.1365-2133.2009.09076.x. Epub 2009 Mar 9. No abstract available.

PMID:
19292713
11.

Successful administration of cytarabine in a 16-month-old girl with acute myelogenous leukemia and cytarabine syndrome.

Metz KA, Johnson T, Hershey GK, Lierl MB, Seidu L, Burns K, Assa'ad A.

Ann Allergy Asthma Immunol. 2009 Feb;102(2):173-4. doi: 10.1016/S1081-1206(10)60254-2. No abstract available.

PMID:
19230475
12.

Acute anterior uveitis in primary care.

Gutteridge IF, Hall AJ.

Clin Exp Optom. 2007 Sep;90(5):390; author reply 390. No abstract available.

PMID:
17697189
13.

Cytosine-arabinoside induced bradycardia in patient with non-Hodgkin lymphoma: a case report.

Cil T, Kaplan MA, Altintas A, Pasa S, Isikdogan A.

Leuk Lymphoma. 2007 Jun;48(6):1247-9. No abstract available.

PMID:
17577797
14.

Flushing out of cerebrospinal fluid as a therapy for acute cerebellar dysfunction caused by high dose of cytosine arabinoside: a case report.

Pellier I, Leboucher B, Rachieru P, Ifrah N, Rialland X.

J Pediatr Hematol Oncol. 2006 Dec;28(12):837-9.

PMID:
17164656
15.

Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia.

Saito T, Asai O, Dobashi N, Yano S, Osawa H, Takei Y, Takahara S, Ogasawara Y, Yamaguchi Y, Minami J, Usui N.

J Infect Chemother. 2006 Jun;12(3):148-51.

PMID:
16826348
16.

A case of hypopyon uveitis nonresponsive to steroid therapy and a review of anterior segment masquerade syndromes in childhood.

Birnbaum AD, Tessler HH, Goldstein DA.

J Pediatr Ophthalmol Strabismus. 2005 Nov-Dec;42(6):372-7.

PMID:
16382564
17.

Hepatotoxicity due to a possible interaction between cytosine arabinoside and dipyridamole: a case report.

Babaoglu MO, Karadag O, Saikawa Y, Altundag K, Elkiran T, Yasar U, Bozkurt A.

Eur J Clin Pharmacol. 2004 Aug;60(6):455-6. Epub 2004 Jul 1. No abstract available.

PMID:
15232664
18.

Anterior uveitis as a complication of treatment with high dose cytosine-arabinoside.

Planer D, Cukierman T, Liebster D, Ilsar M, Chajek-Shaul T.

Am J Hematol. 2004 Jul;76(3):304-6.

PMID:
15224375
19.

[Ocular hypotonia in leukemia].

Hackethal U, Holzapfel C, Husstedt I, Gerding H.

Ophthalmologe. 2004 Jan;101(1):80-2. German. No abstract available.

PMID:
14872273
20.

Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinoside.

Hogan WJ, Letendre L, Litzow MR, Tefferi A, Hoagland HC, Pruthi RK, Kaufmann SH.

Mayo Clin Proc. 2002 Aug;77(8):760-2.

PMID:
12173711
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk